Feb 22, 20233 min readUpcoming Pegozafermin NASH Readout!Summary: The upcoming readout from ETNB includes Phase 2b data from the pegozafermin trial in NASH. This is a Suspected Mover for Q1...
Jun 21, 20223 min readBiopharma Daily Stock Updates - 06/21/22$XBI $70.03 | +3.58% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #OCGN +4.6% Ocugen Announces...
Jun 21, 20223 min readFree Biopharma Daily Stock Updates - 06/21/22$XBI $70.03 | +3.58% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #OCGN +4.6% Ocugen Announces...